Abstract: A managing unit manages an identifier for identifying an authenticated container that is authenticated as a legitimate container. An inquiring unit inquires, before transferring a substance between containers, the managing unit whether both of the containers are the authenticated containers. An approving unit approves a transaction of the substance, upon acquiring a response from the inquiring unit saying that both of the containers are the authenticated containers.

Abstract: A managing unit manages an identifier for identifying an authenticated container that is authenticated as a legitimate container. An inquiring unit inquires, before transferring a substance between containers, the managing unit whether both of the containers are the authenticated containers. An approving unit approves a transaction of the substance, upon acquiring a response from the inquiring unit saying that both of the containers are the authenticated containers.

Abstract: This invention is to provide a technique to appropriately authenticate the requesting side and the diagnosis side in the remote diagnosis system. In this invention, an authentication server communicating with a diagnosis requesting side terminal and a diagnosis side terminal carries out: at the beginning of a remote diagnosis, judging whether or not an image obtained in the diagnosis requesting side terminal satisfies a first condition; at the beginning of the remote diagnosis, judging whether or not an image obtained by the diagnosis side terminal satisfies a second condition; and upon detection that affirmative judgments are obtained in the first and second judgings, generating authentication data including information concerning the diagnosis requesting side terminal, information concerning the diagnosis side terminal and a diagnosis time. Accordingly, it is possible to guarantee that both terminals have an appropriate capability and etc.

Abstract: Disclosed are compounds represented by formula (I) which have triglyceride biosynthesis inhibitory activity in the liver and inhibitory activity against the secretion of apolipoprotein B-containing lipoprotein from the liver and particularly have excellent inhibitory activity against the secretion of apolipoprotein B-containing lipoprotein, are free from side effect of accumulation of lipids in the liver, and are useful for the treatment and prevention of hyperlipidemia and arteriosclerotic diseases.

Abstract: Disclosed are compounds represented by formula (I) which have triglyceride biosynthesis inhibitory activity in the liver and inhibitory activity against the secretion of apolipoprotein B-containing lipoprotein from the liver and particularly have excellent inhibitory activity against the secretion of apolipoprotein B-containing lipoprotein, are free from side effect of accumulation of lipids in the liver, and are useful for the treatment and prevention of hyperlipidemia and arteriosclerotic diseases.

Abstract: Disclosed are compounds represented by formula (I) which have triglyceride biosynthesis inhibitory activity in the liver and inhibitory activity against the secretion of apolipoprotein B-containing lipoprotein from the liver and particularly have excellent inhibitory activity against the secretion of apolipoprotein B-containing lipoprotein, are free from side effect of accumulation of lipids in the liver, and are useful for the treatment and prevention of hyperlipidemia and arteriosclerotic diseases.

Abstract: A compound represented by the following general formula (I) and a pharmacologically acceptable salt thereof: wherein R1 represents hydrogen atom, an alkyl group, a substituted alkyl group and the like; R2 and R3 represent hydrogen atom, an alkyl group, a substituted alkyl group, an alkoxyl group and the like; X represents —CH2—, —O—, or —NH—; A represents the following group (II): [in which R7 and R8 represent hydrogen atom, an alkyl group, an acyl group, an alkoxycarbonyl group and the like; R9 and R10 represents hydrogen atom, a halogen atom, hydroxyl group, phenyl group, an alkyl group and the like] and the like; and E represents hydrogen atom and the like, which has inhibitory activity against carboxypeptidase B and is useful for therapeutic and/or preventive treatment of a thrombotic disease.

Abstract: A compound represented by the following general formula (I) and a pharmacologically acceptable salt thereof: 1

Abstract: Disclosed are compounds represented by formula (I) and pharmaceutically acceptable salts and solvates thereof. The compounds can inhibit the biosynthesis of triglycerides in the liver and can inhibit the secretion of lipoprotein containing apolipoprotein B from the liver. Therefore, they are useful for the prevention or treatment of hyperlipidemia (particularly hyper-very-low-density-lipoproteinemia) and arteriosclerotic diseases, such as cardiac infarction, or pancreatitis induced by hyperlipidemia.

Abstract: A compound represented by the following general formula (I) and a pharmacologically acceptable salt thereof: wherein R1 represents hydrogen atom, an alkyl group, a substituted alkyl group and the like; R2 and R3 represent hydrogen atom, an alkyl group, a substituted alkyl group, an alkoxyl group and the like; X represents —CH2—, —O—, or —NH—; A represents the following group (II): [in which R7 and R8 represent hydrogen atom, an alkyl group, an acyl group, an alkoxycarbonyl group and the like; R9 and R10 represents hydrogen atom, a halogen atom, hydroxyl group, phenyl group, an alkyl group and the like] and the like; and E represents hydrogen atom and the like, which has inhibitory activity against carboxypeptidase B and is useful for therapeutic and/or preventive treatment of a thrombotic disease.

Abstract: Disclosed are compounds represented by formula (I) and pharmaceutically acceptable salts and solvates thereof. The compounds can inhibit the biosynthesis of triglycerides in the liver and can inhibit the secretion of lipoprotein containing apolipoprotein B from the liver. Therefore, they are useful for the prevention or treatment of hyperlipidemia (particularly hyper-very-low-density-lipoproteinemia) and arteriosclerotic diseases, such as cardiac infarction, or pancreatitis induced by hyperlipidemia.

Abstract: Disclosed are compounds represented by formula (I) and pharmaceutically acceptable salts and solvates thereof. The compounds can inhibit the biosynthesis of triglycerides in the liver and can inhibit the secretion of lipoprotein containing apolipoprotein B from the liver. Therefore, they are useful for the prevention or treatment of hyperlipidemia (particularly hyper-very-low-density-lipoproteinemia) and arteriosclerotic diseases, such as cardiac infarction, or pancreatitis induced by hyperlipidemia.

Abstract: There is provided an ultrasonic diagnostic apparatus in which transmission of ultrasonic waves into the subject and reception of the ultrasonic waves reflected within the subject are repeatedly performed to obtain a plurality of sequentially continued frames of image data, and a dynamic image is displayed in accordance with the image data thus obtained. According to the ultrasonic diagnostic apparatus, image data, which is transmitted to a storage unit for the purpose of an average arithmetic operation for the successive frame K+1, is selected for each pixel I from between two types of image data of an averaging image data B (K, I) after an average arithmetic operation processing and a new frame of image data A (K, I) before the average arithmetic operation processing. Thus, both the reduction of noises and the tracking ability to the movement are implemented with greater satisfaction.

Abstract: An ultrasonic diagnostic apparatus in which ultrasonic waves are transmitted into the subject, the ultrasonic waves reflected within the subject are received to obtain received signals, and an image is produced in accordance with the received signals thus obtained. Several reception scanning lines are formed in a transmission ultrasonic beam. Several images thus obtained are superimposed on one another or combined together. Using this device deterioration of the picture quality due to multiple reflections or multiple echoes is prevented.

Abstract: An acoustic imaging system includes pairs of variable gain amplifiers for deriving essentially pairs of signals from respective signals generated in respective ultrasonic vibrators and the pairs of signals are superimposed on each other in a time difference corresponding to a phase angle of .pi./2 in frequency of ultrasonic waves. Amplification factors of the variable gain amplifiers are controlled so that the desired phase shift of the superimposed signals is obtained to attain dynamic focusing. Another acoustic imaging system includes a switch circuit having a two stage matrix switches construction that performs matrix switch functions in a smaller number of switch elements. Still another acoustic imaging system includes constituents for the aforementioned phase control for fine adjustment of delay time, the aforementioned switch circuit for rough adjustment of delay time, and variable gain amplifiers that perform smooth switching of the delay time.

Abstract: An ultrasonic diagnostic apparatus including ultrasonic transducers. The ultrasonic diagnostic apparatus performs calculations for respective ultrasonic transducers to determine at which focal position a signal having just been received by the transducers is reflected in accordance with a lapse of time from a time when ultrasonic waves are transmitted. A delay time of respective received signals obtained from the transducers are determined in accordance with the results of the calculations. According to the present invention, control data which determines the delay time is stored in a first stored apparatus, compensation data which compensates the control data is stored in a second storage apparatus. The control data and compensation data read out respectively from these first and second storage apparatuses are added to one another, and the delay time for transmission and reception is determined according to the sum of the control data and compensation data.

Abstract: An ultrasonic wave beam former including: a ultrasonic wave probe (1) equipped with a plurality of transducers (2) for converting a ultrasonic wave signal to an electric signal for effecting a dynamic focus by multiplying each channel signal as an output signal from each of the transducers (2) by a reference wave signal having the phase which is dynamically adjusted for each channel, and adding together each after-multiplication signal after the multiplication through a delay line (3), characterized in that at least two kinds of reference signals having mutually different frequencies are provided for each of the channels and at least two multipliers (10) are also provided;each of the reference signals is constituted so as to receive an ultrasonic wave signal from a direction differenct from others and have a phase angle (.theta.

Abstract: Disclosed is an ultrasonic receiving apparatus for use with an ultrasonic diagnosis system, the apparatus containing digital delaying means and/or digital adding means. The delaying means provides delays of sufficiently high accuracy using a clock signal of a reasonably high repeat frequency on a reasonable scale of circuit construction, while the adding means allows for larger probe aperture.(1) The delaying means has delay circuits each offering a delay in units of the clock signal cycle, and infinitesimal delaying circuits each multiplying two signals derived from a single reception signal, one of the two signals being delayed relative to the other before the two are added.

Abstract: An amplitude variable pulse generator is provided with two voltage supply sources. The first voltage source supplies a variable voltage which determines the amplitude of the output pulse. The second voltage source is a fixed or constant voltage source which provides a voltage lower in value than the first voltage. The second voltage source quickly pulls up a voltage between a drain and a source of a switching MOSFET, which generates the output pulse, by providing a charging voltage for an output capacitance of the MOSFET. By doing so, the output capacitance of the MOSFET is quickly reduced, and the trailing edge of the output pulse is not rounded even when the variable voltage is low. As a result, the waveform of the output pulse is not rounded for a very small amplitude pulse. Resolution of a supersonic wave device especially a supersonic diagnostic device is thereby improved.